
Park Ha Biological (PHH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
3.1M
Total Liabilities
1.6M
Shareholders Equity
1.5M
Debt to Equity
1.05
Cash Flow Metrics
Revenue & Profitability Trend
Park Ha Biological Income Statement From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue | 2.4M | 2.5M | 1.9M | 931.0K |
Cost of Goods Sold | 195.3K | 311.0K | 509.2K | 311.2K |
Gross Profit | 2.2M | 2.1M | 1.4M | 619.9K |
Gross Margin % | 91.8% | 87.4% | 73.5% | 66.6% |
Operating Expenses | ||||
Research & Development | 36.7K | 30.9K | 60.7K | - |
Selling, General & Administrative | 1.2M | 784.6K | 1.1M | 1.1M |
Other Operating Expenses | - | - | - | - |
Total Operating Expenses | 1.2M | 815.5K | 1.2M | 1.1M |
Operating Income | 793.7K | 1.2M | 197.0K | -501.0K |
Operating Margin % | 33.3% | 48.0% | 10.3% | -53.8% |
Non-Operating Items | ||||
Interest Income | 783 | 1.6K | 263 | 167 |
Interest Expense | - | 0 | 194 | 1.2K |
Other Non-Operating Income | -1.1K | -575 | -7.1K | 17.0K |
Pre-tax Income | 793.4K | 1.2M | 190.0K | -485.0K |
Income Tax | 314.9K | 329.5K | -1.3K | 0 |
Effective Tax Rate % | 39.7% | 27.9% | -0.7% | 0.0% |
Net Income | 478.6K | 852.0K | 191.3K | -485.0K |
Net Margin % | 20.1% | 34.6% | 10.0% | -52.1% |
Key Metrics | ||||
EBITDA | 816.4K | 1.2M | 220.7K | -444.8K |
EPS (Basic) | - | $0.03 | $0.01 | $-0.02 |
EPS (Diluted) | - | $0.03 | $0.01 | $-0.02 |
Basic Shares Outstanding | - | 26200000 | 26200000 | 26200000 |
Diluted Shares Outstanding | - | 26200000 | 26200000 | 26200000 |
Income Statement Trend
Park Ha Biological Balance Sheet From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 547.5K | 1.0M | 574.7K | 72.7K |
Short-term Investments | - | - | - | - |
Accounts Receivable | 330.9K | 361.7K | 119.2K | 52.0K |
Inventory | 71.5K | 95.9K | 94.2K | 316.5K |
Other Current Assets | - | - | - | - |
Total Current Assets | 2.8M | 2.2M | 2.3M | 473.6K |
Non-Current Assets | ||||
Property, Plant & Equipment | 70.7K | 31.9K | 27.8K | 36.9K |
Goodwill | 7.6K | 8.4K | 9.3K | 0 |
Intangible Assets | 7.6K | 8.4K | 9.3K | - |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | 56.3K | 0 | 178.1K | - |
Total Non-Current Assets | 239.0K | 88.7K | 254.1K | 120.6K |
Total Assets | 3.1M | 2.3M | 2.5M | 594.2K |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 24.1K | 197.2K | 129.7K | 89.3K |
Short-term Debt | 17.6K | 22.0K | 26.2K | 19.3K |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | - | - | - | - |
Total Current Liabilities | 1.5M | 1.2M | 2.4M | 1.2M |
Non-Current Liabilities | ||||
Long-term Debt | 52.7K | 9.5K | 0 | 15.9K |
Deferred Tax Liabilities | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - |
Total Non-Current Liabilities | 52.7K | 9.5K | 0 | 15.9K |
Total Liabilities | 1.6M | 1.3M | 2.4M | 1.2M |
Equity | ||||
Common Stock | 500 | 500 | 500 | 500 |
Retained Earnings | 271.8K | -105.2K | -926.9K | -1.1M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 1.5M | 1.0M | 150.3K | -578.2K |
Key Metrics | ||||
Total Debt | 70.3K | 31.5K | 26.2K | 35.2K |
Working Capital | 1.3M | 933.2K | -103.8K | -682.9K |
Balance Sheet Composition
Park Ha Biological Cash Flow Statement From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 478.6K | 852.0K | 191.3K | -485.0K |
Depreciation & Amortization | 22.7K | 20.1K | 30.5K | 39.0K |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | -253.4K | -1.4M | 1.1M | -151.1K |
Operating Cash Flow | 256.9K | -508.4K | 1.3M | -595.4K |
Investing Activities | ||||
Capital Expenditures | -85.6K | -22.7K | -11.9K | -12.9K |
Acquisitions | - | - | - | - |
Investment Purchases | - | - | - | - |
Investment Sales | - | - | - | - |
Investing Cash Flow | -508.1K | 1.0M | -1.5M | -12.9K |
Financing Activities | ||||
Share Repurchases | - | - | - | - |
Dividends Paid | - | - | - | - |
Debt Issuance | 4.2K | 60.9K | 393.1K | 631.1K |
Debt Repayment | -73.3K | -776.1K | -257.6K | -395.5K |
Financing Cash Flow | -957.4K | -676.9K | 669.7K | 498.6K |
Free Cash Flow | 874.9K | 103.9K | 1.4M | -510.8K |
Net Change in Cash | -1.2M | -161.9K | 433.9K | -109.7K |
Cash Flow Trend
Park Ha Biological Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
26.34
Price to Book
3.08
Price to Sales
4.73
Profitability Ratios
Profit Margin
91.80%
Operating Margin
-1,591.00%
Return on Equity
-729.77%
Return on Assets
-298.12%
Financial Health
Current Ratio
3.68
Debt to Equity
2.15
Per Share Data
EPS (TTM)
$-0.72
Book Value per Share
$0.15
Revenue per Share
$0.11
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
phh | 12.9M | 26.34 | 3.08 | -729.77% | 91.80% | 2.15 |
Procter & Gamble | 374.8B | 24.54 | 7.30 | 31.24% | 18.95% | 69.86 |
Colgate-Palmolive | 68.8B | 23.54 | 96.44 | 398.04% | 14.54% | 832.51 |
Acme United | 168.8M | 17.42 | 1.48 | 9.50% | 5.33% | 30.04 |
European Wax Center | 110.0M | 21.45 | 2.43 | 11.72% | 4.21% | 360.28 |
Big Tree Cloud | 75.3M | 44.00 | - | -13.99% | 8.75% | -0.42 |
Financial data is updated regularly. All figures are in the company's reporting currency.